# Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

> **NCT00001445** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 32 (—)

## Conditions studied

- HIV Infection

## Interventions

- **BIOLOGICAL:** HIV-1 Immunogen

## Key facts

- **NCT ID:** NCT00001445
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-08
- **Primary completion:** —
- **Final completion:** 2001-07
- **Target enrollment:** 32 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001445, "Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*